Privia Health Group, Inc. logo

Privia Health Group, Inc. (PRVA)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
22. 52
-0.1
-0.4421%
$
2.63B Market Cap
93.79 P/E Ratio
- Div Yield
1.25M Volume
0.24 Eps
$ 22.62
Previous Close
Add Transaction
Day Range
22.39 22.8
Year Range
18.91 28.82
Want to track PRVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates

Privia Health (PRVA) Q4 Earnings and Revenues Beat Estimates

Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago.

Zacks | 7 months ago
Curious about Privia Health (PRVA) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Curious about Privia Health (PRVA) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Evaluate the expected performance of Privia Health (PRVA) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks | 7 months ago
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q3 Earnings

Here's What Key Metrics Tell Us About Privia Health (PRVA) Q3 Earnings

The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 11 months ago
Privia Health (PRVA) Lags Q3 Earnings Estimates

Privia Health (PRVA) Lags Q3 Earnings Estimates

Privia Health (PRVA) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.03 per share a year ago.

Zacks | 11 months ago
Privia Health's Premium: A Breakout Play

Privia Health's Premium: A Breakout Play

Privia Health Group offers high-growth potential with a recurring revenue model and strong relationships, making it attractive amid the healthcare sector underperformance. PRVA's recent acquisition of Evolent Health's ACO adds over 120,000 users, boosting revenue streams and raising expectations for the next earnings report. Despite a high forward P/E and a DCF model suggesting downside, technical patterns and sector comps support a potential breakout above $26, targeting $28–$36.

Seekingalpha | 11 months ago
Privia Health Group, Inc. (PRVA) Q2 2025 Earnings Call Transcript

Privia Health Group, Inc. (PRVA) Q2 2025 Earnings Call Transcript

Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants David Mountcastle - Executive VP, CFO & Principal Accounting Officer Parth Mehrotra - CEO & Director Robert P. Borchert - Senior Vice President of Investor Relations & Corporate Communications Conference Call Participants Albert J.

Seekingalpha | 1 year ago
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics

Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 1 year ago
Privia Health (PRVA) Misses Q2 Earnings Estimates

Privia Health (PRVA) Misses Q2 Earnings Estimates

Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.03 per share a year ago.

Zacks | 1 year ago
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript

Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript

Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor and Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Truist Josh Raskin - Nephron Research Richard Close - Canaccord Matthew Gillmor - KeyBanc Jessica Tassan - Piper Sandler Alberta Massey - Leerink Partners A.J. Rice - UBS Thomas Walsh - Barclays Ryan Langston - TD Cowen Elizabeth Anderson - Evercore ISI Constantine Davides - Citizens JMP Jack Slevin - Jefferies Jeff Garro - Stephens Ryan Daniels - William Blair David Larsen - BTIG Matt Shea - Needham Jamie Perse - Goldman Sachs Daniel Grosslight - Citi Michael Ha - Baird Joanna Gajuk - Bank of America Operator Thank you for standing by.

Seekingalpha | 1 year ago
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say

Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 1 year ago
Privia Health (PRVA) Misses Q1 Earnings Estimates

Privia Health (PRVA) Misses Q1 Earnings Estimates

Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.

Zacks | 1 year ago
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 1 year ago
Loading...
Load More